title: Aortitis during etanercept therapy for ankylosing spondylitis: finding the culprit.
authors.forename: Frank
authors.initials: F
authors.lastname: Verhoeven
authors.forename: Marie
authors.initials: M
authors.lastname: Bossert
authors.forename: Anne
authors.initials: A
authors.lastname: Lohse-Walliser
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Balblanc
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001025:Aortitis / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D000068800:Etanercept; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D049268:Positron-Emission Tomography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D028761:Withholding Treatment
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept; D008727:Methotrexate